These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2007-003126-15 Randomized trial of sequential epirubicin and docetaxel against docetaxel in patients with early operable breast cancer. bad-data
Not reported Terminated 2008-005067-33 Randomized trial of endocrine therapy against locoregional therapy first. A DBCG trial in postmenopausal patients with operable hormone receptor positive tumors larger than 1 cm. 2012-12-31 due-trials
Completed, but no date Terminated 2012-002347-23 Phase II study of irinotecan weekly in combination with trastuzumab in patients with locally advanced or metastatic HER2-positive breast cancer and increased cancer cell copy number of TOP1” bad-data
Completed, but no date Terminated 2012-002348-26 Phase II study of irinotecan weekly in patients with locally advanced or metastatic HER2-negative breast cancer and increased cancer cell copy number of the topoisomerase 1 gene (TOP1)” bad-data